Bioassay of EDRF from internal mammary arteries: Implications for early and late bypass graft patency
- 1 December 1992
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 54 (6) , 1078-1084
- https://doi.org/10.1016/0003-4975(92)90073-d
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Production of endothelium-derived contracting factor is enhanced after coronary reperfusionThe Annals of Thoracic Surgery, 1991
- Control of coronary vascular tone by nitric oxide.Circulation Research, 1990
- Endothelium‐derived nitric oxide: actions and propertiesThe FASEB Journal, 1989
- Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non‐vascular smooth muscleBritish Journal of Pharmacology, 1988
- Difference between Endothelium-Dependent Relaxation in Arterial and in Venous Coronary Bypass GraftsNew England Journal of Medicine, 1988
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMPublished by Elsevier ,1987
- The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBritish Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986